Health & Science
Accurate diagnosis is the foundation of effective medical care, yet hundreds of thousands of Americans are harmed each year by misdiagnosis. Improving outcomes will require not just better technology but a renewed emphasis on bedside skills, observation and human connection.
Northwestern researchers discovered that an experimental drug called NU-9 shows promise as an early intervention for Alzheimer’s disease. Invented by chemistry professor Richard Silverman, NU-9 is a small molecule compound that is currently being tested as a treatment for ALS.
Lyme disease poses a serious threat to public health. Professor Brandon Jutras and his research team have made breakthrough discoveries that could improve treatment options and could also explain why some patients continue to experience chronic Lyme symptoms.
Professor John Rogers shares how the new Querrey Simpson Institute for Translational Engineering for Advanced Medical Systems (QSI-TEAMS) will help bring breakthrough medical technologies to market.
In a partnership with the Chicago Botanic Garden, faculty, students and alumni of Northwestern’s Program in Plant Biology and Conservation study carnivorous plants, tequila’s source, life in forest canopies and more.
Created by Northwestern engineering professor Nick Marchuk ’10 MS and David Meyer ’12 MS, ’15 PhD, nLab is a credit card–sized device that turns your laptop into an electronics lab and gives students a chance to practice hands-on circuit-building.
Northwestern engineers have developed a new strategy that disables cancer cells’ ability to adapt, making them more vulnerable to treatment. The approach increases chemotherapy’s effectiveness and could lead to more successful therapies.
Launched in 2024, Northwestern’s Center for Engineering in Vision and Ophthalmology (CEVO) is using artificial intelligence and other cutting-edge technology to advance its glaucoma research. Backed by a gift from the Forsythe Family Foundation, CEVO is developing innovative imaging tools to better understand and treat the disease, one of the world’s leading causes of permanent blindness.
Professor Jonathan Rivnay and his team have designed biohybrid implantable devices that can manufacture and dispense medicine on demand from within the body. These “living pharmacies” could have broad applications, delivering therapies for illnesses such as cancer, diabetes and more.
Northwestern engineering students took the top prize at NASA’s 2024 Breakthrough, Innovative and Game-Changing (BIG) Idea Challenge, which asked teams to develop inflatable systems that could benefit future lunar missions.
